Ofloxacin is a synthetic, broad-spectrum, second-generation fluoroquinolone antibiotic that is an analog of nalidixic acid. It was developed by Daiichi Seiyaku to be resistant to metabolic oxidation in the liver and inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication. It is used to combat organisms causing urinary tract and respiratory infections.